CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Persistence of KIR(neg) NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation.
Persistence of KIR(neg) NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
单倍体相合造血干细胞移植(h-HSCT)是治愈血液系统恶性肿瘤患者的一种治疗选择。免疫重建(IR)的动力学和质量影响 h-HSCT 的临床结局,并限制危及生命的人巨细胞病毒(HCMV)感染/再激活的发生。自然杀伤(NK)细胞是 h-HSCT 后最早恢复的淋巴细胞,它们能够对机会性病原体提供快速的固有免疫应答。通过对多参数流式细胞术数据进行纵向单细胞分析,我们在此表明,CD158b1b2j neg /NKG2A pos /NKG2C neg /NKp30 pos /NKp46 pos(KIR neg)NK 细胞以高频率持续存在与 HCMV 感染/再激活的控制相关。这些 KIR neg NK 细胞是“未获许可”的,并且不是终末分化淋巴细胞,它们在 IR 早期出现,主要属于 CD56 bright /CD16 neg 和 CD56 bright /CD16 pos 亚群。KIR neg NK 细胞富集于氧化和葡萄糖代谢通路,产生干扰素-γ,并在离体条件下对 HCMV 具有强效抗病毒活性。IR 早期 KIR neg NK 细胞频率降低与临床相关的 HCMV 复制相关。
综上所述,我们的发现表明,h-HSCT 后 KIR neg NK 细胞的长期持续存在可作为生物标志物,以更好地预测 HCMV 感染/再激活。这一现象也为通过用 KIR neg NK 细胞富集移植后供者淋巴细胞输注来优化抗病毒免疫应答铺平了道路。
Haploidentical hematopoietic stem cell transplantation (h-HSCT) is a therapeutic option to cure patients affected by hematologic malignancies. The kinetics and the quality of immune-reconstitution (IR) impact the clinical outcome of h-HSCT and limit the onset of life-threatening Human Cytomegalovirus (HCMV) infection/reactivation. Natural Killer (NK) cells are the first lymphocytes that recover after h-HSCT and they can provide rapid innate immune responses against opportunistic pathogens. By performing a longitudinal single-cell analysis of multiparametric flow-cytometry data, we show here that the persistence at high frequencies of CD158b1b2j neg /NKG2A pos /NKG2C neg /NKp30 pos /NKp46 pos (KIR neg ) NK cells is associated with HCMV infection/reactivation control.
These KIR neg NK cells are "unlicensed", and are not terminal-differentiated lymphocytes appearing early during IR and mainly belonging to CD56 bright /CD16 neg and CD56 bright /CD16 pos subsets. KIR neg NK cells are enriched in oxidative and glucose metabolism pathways, produce interferon-γ, and are endowed with potent antiviral activity against HCMV ex vivo .
Decreased frequencies of KIR neg NK cells early during IR are associated with clinically relevant HCMV replication. Taken together, our findings indicate that the prolonged persistence of KIR neg NK cells after h-HSCT could serve as a biomarker to better predict HCMV infection/reactivation. This phenomenon also paves the way to optimize anti-viral immune responses by enriching post-transplant donor lymphocyte infusions with KIR neg NK cells.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。